A revolutionary schizophrenia treatment developed in Israel, which makes it easier for adult patients to manage their illness, has been granted approval by the US Food and Drug Administration, clearing the way for it to reach Americans in need as soon as this month.  Pharmaceutical companies Teva of Israel and Medincell of France have teamed […]

AION Labs, is a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science

Israel’s Teva is partnering with the Technion for research into new immunotherapy methods to treat cancer and nervous system diseases.

The Israeli pharmaceutical giant signed separate agreements with the universities for innovative drug research and development with a focus on cancer treatments.

Teva's is the first generic naloxone hydrochloride nasal spray approved by the FDA.

The Israel-based company's generic alternative for US sufferers of anaphylaxis comes two years after Mylan raised the price of its branded drug EpiPen to $600.